Emerging Technologies in Drug Discovery and Development

Shanghai, September 23-25, 2024.

Below is the list of the confirmed speakers. More speakers will be added in the following weeks.

 

Klara Valko, CEO, Biomimetic chromatography Ltd., UK

Ao Zhang, Professor and Dean, Shanghai Jiao Tong University College of Pharmaceutical Sciences, China
张翱 教授, 上海交通大学药学院

Johan Gabrielsson, Professor of integrative pharmacology, Uppsala, Sweden

Ning Jiao, Professor, School of Pharmaceutical Sciences, Peking University
焦宁 教授, 北京大学药学院

Alex Avdeef, CEO, In ADME Research, USA

Qiyue Hu, Founder and CEO, Beyang Therapeutics, China
胡齐悦, 苏州必扬医药科技有限公司

Christel Bergström, Professor, Uppsala University, Sweden

Xiaobao YangPh.D., Founder, Chairman and Chief Executive Officer, Gluetacs Therapeutics, China
杨小宝 博士-标新生物创始人, 董事长兼首席执行官

Annette Bauer-Brandl, Professor, University of Southern Denmark

Godefridus J. Peters, VU University Medical Center Amsterdam, The Netherlands

Tonglei Li, Professor, Purdue University, USA 

Houfu LiuPh.D., Vice President, Clinical Pharmacology/DMPK, SciNeuro Therapeutics Inc, China
刘厚甫 博士, 赛神(上海)医药科技有限公司

Likun Wang, Ph.D., Founder & General Manager,Nanjing HaiWei Pharmaceutical Technologies Co., Ltd
王立坤 博士, 海维医药创始人兼总经理

Xiaoqiang Xiang, Ph.D., Professor, School of Pharmacy, Fudan University, China
相小强 教授, 复旦大学药学院

Dafang Zhong, Ph.D., Professor and PI, Shanghai Institute of Materia Medica, Chinese Academy of Sciences
钟大放 教授, 中国科学院上海药物研究所

Ren Hongcan, Ph.D, GenFleet, China
任洪灿 博士, 劲方医药

Tatjana Verbić, Professor, University of Belgrade, Serbia

Jingwu Kang, Ph.D. Professor, Shanghai Institute of Organic Chemistry, Chinese Academy of Science (CAS)
康经武 博士,  中国科学院上海有机化学研究所

Hassan Karimi-Maleh, Professor, University of Electronics Science and Technology of China

Weikang Tao, Ph.D., MD, Corp VP and General Manager of Global R&D of Innovative Medicines, Qilu Pharmaceuticals
陶维康, 博士, 总经理, 齐鲁制药集团全球创新研发

Kin Tam, Professor, Faculty of Health Sciences, University of Macau, Chief Editor of ADMET & DMPK, Macau

Shun Xiao, Ph.D.Head and Sr. Director, Analytical R&D and Quality Control, Ascentage Pharma
亚盛医药分析研发与质量控制高级总监肖舜博士

Kiyohiko Sugano, Professor, Ritsumeikan University, Japan

Xiancheng Zeng, Ph.D., VP, Preclinical Toxicology Research of Medicilon
曾宪成 博士, 美迪西 临床前毒理研究部 副总裁

Defang Ouyang, Ph.D., PI, Institute of Chinese Medical Sciences, University of Macau
欧阳德方 博士, 澳门大学中华医药研究院 教授

Jiyue Zhang, Aubrak Therapeutics, co-founder & CEO
张继跃 博士, 奥瑞药业 首席执行官

Yuanfeng Xia, Ph.D., Executive Director, Head of biology in small molecule discovery department in GenSci Pharma.
夏远峰 博士,金赛药业化药研发中心生物部门负责人,执行总监 

Wei Li, Ph. D., Founder and CEO, Tianjin Ruicheng Jianda Medical Technology Co., Ltd.
李伟 博士, 天津瑞程健达医药科技有限公司 创始人和首席执行官

Wenfu Tan, MD. School of Pharmacy, Fudan University
谭文福 博士, 复旦大学药学院

Yan Feng, Ph. D.,CEO and Founder, Shanghai Leadingtac Pharmaceutical Co. Ltd.
冯焱 博士,上海领泰生物医药科技有限公司 创始人兼CEO

Boxun Lu, Ph.D., Professor,Fudan University
鲁伯埙 博士, 复旦大学 教授

Li Zeng, Ph.D., CEO of Jing Medicine
曾雳 博士, 和径医药科技(上海)有限公司 首席执行官

Zhuang Xiaomei, Ph.D., Research fellow of the Institute of Pharmacology and Toxicology, AMMS
庄笑梅 博士, 军事医学研究院毒物药物研究所 研究员

Dongyang Liu,  Ph.D.,  Professor & Director of Clinical Pharmacology and Pharmacometrics Office (CPPO), and Deputy Director of Drug Clinical Trial Center of Peking University Third Hospital (PUTH)
刘东阳,研究员,博士生导师,北医三院药物临床试验机构副主任,兼任其临床药理与定量药理研究室负责人、北京市心血管受体研究重点实验室副主任、北医三院-新领先改良型新药智慧开发联合研发中心主任

Hua He, Ph.D., Associate Professor of China Pharmaceutical University
何华博士, 中国药科大学 副教授

Xueming Liu, Ph.D.,Vice President, Chemistry, Manufacturing and Controls, Haihe Biopharma Co. Ltd.
刘学明 博士, 上海海和药物研究开发股份有限公司 副总裁

Yanyan ZhangPh.D., Senior Director, Clinical Pharmacology, AstraZeneca China
张延延 博士, 临床药理 高级总监,  阿斯利康(中国

Weiwen Ying, Ph.D., Founder and CEO of Ranok Therapeutics
英伟文 博士, 珃诺生物医药科技 (杭州有限公司) 创始人, 首席执行官

Yong Cang, PhD, Professor, ShanghaiTech University School of Life Science and Technology
仓勇 博士,上海科技大学生命科学与技术学院 教授

Carolina (Lina) Säll, PhD, Principal Scientist, Development ADME, Novo Nordisk A/S, Denmark

Shenaz Bunally, PhD, Associate director, GlaxoSmithKline, UK

Huiping Amy Guan, PhD, Chief Technology Officer, Uprotech Pharmaceutical Inc.
关慧平 博士, 首席技术官, 优济普世医药科技有限公司

Jashvant D. Unadkat, Ph.D., University of Washington, Seattle, WA

Wandong Zhang, M.D., Ph.D., Principal Research Officer/Adjunct Professor, Human Health Therapeutics Research Centre, National Research Council of Canada, Dept. of Cellular & Molecular Medicine, Faculty of Medicine, University of Ottawa
张万东, 加拿大国家研究院首席科学家, 加拿大渥太华大学医学院兼职教授

Longwei Sun, Ph.D., Director of CMC, Formulation Head, Asieris Pharmaceuticals
孙龙伟 博士,上海亚虹医药有限公司 CMC总监

Wei Zhu, Ph.D., (朱伟), Head of Medicinal Chemistry, China Innovation Center of Roche (CICoR)
罗氏中国创新中心

Yun Zhang, Ph.D., DABT, DSTL, Pfizer, USA 

Xu ZhangPh.D., Vice President, ICE Bioscience InC.
张旭博士, 爱思益普生物 副总裁 

Haiyan Ying, PhD, Executive director, Discovery Biology, Abbisko Therapeutics, China
应海燕 博士,和誉医药生物发现执行 总监 

Li Ma, Senior Principal Scientific Researcher, Genentech, USA

Wei Li, Associate Director, Suzhou Novartis Technical Development Co., Ltd., China
苏州诺华医药科技研发有限公司

Jieyu Dai, PhD,Associate Director, Johnson & Johnson, China
戴洁玉, 博士, 强生 

Irena Loryan, Assoc. Prof., Uppsala University Sweden